Piramal Pharma Limited Open Interest & PCR Analysis
OI Buildup Read
Neutral buildup prevails with spot price unchanged and total options OI stable at 0% net change. This signals balanced participation, with neither bulls nor bears adding fresh positions. The absence of directional OI momentum suggests indecision and range-bound action.
Put-Call Ratio Signal
PCR stands at 0.941, up from yesterday’s 0.872, reflecting a modest shift toward put dominance but still below the 1.0 bullish contrarian threshold. The rise in PCR indicates growing defensive positioning, though not at extreme levels.
Futures Confirmation
Futures OI remains at zero with no open contracts, removing any leverage or sentiment confirmation from the futures segment. This lack of participation weakens the signal integrity of options-based analysis.
Bias for Tomorrow
Bearish bias into expiry with resistance near ₹170; invalidation at ₹175.
Data as of 2026-04-28